Evidence map›Paper›PMID 42041139›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2026

Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye.

Alper Gunduz, Nefise Çuvalcı Öztoprak, Nagehan Didem Sarı, Behice Kurtaran, Yusuf Önlen, Ebubekir Senates, Esra Zerdali, Hasan Karsen, Ayse Batırel, Rıdvan Kara Ali and 35 more

Abstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors.

Alper GunduzDepartment of Infectious Diseases, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0001-9154-844X
Nefise Çuvalcı ÖztoprakDepartment of Infectious Diseases, Antalya Training and Research Hospital, Antalya, Türkiye.ORCID 0000-0001-6382-2229
Nagehan Didem SarıDepartment of Infectious Diseases, İstanbul Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-9400-0997
Behice KurtaranDepartment of Infectious Diseases and Clinical Microbiology, Çukurova University Medical Faculty, Adana, Türkiye.ORCID 0000-0002-2081-4664
Yusuf ÖnlenDepartment of Infectious Diseases and Clinical Microbiology, Mustafa Kemal University Medical Faculty, Hatay, Türkiye.ORCID 0000-0002-8163-1386
Ebubekir SenatesSection of Gastroenterology, Medeniyet University Medical Faculty, İstanbul, Türkiye.ORCID 0000-0002-5804-7552
Esra ZerdaliDepartment of Infectious Diseases, Haseki Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-7023-6639
Hasan KarsenDepartment of Infectious Diseases and Clinical Microbiology, Harran University Medical Faculty, Urfa, Türkiye.ORCID 0000-0003-4890-1361
Ayse BatırelDepartment of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Medical Faculty, Rize, Türkiye.ORCID 0000-0002-6005-636X
Rıdvan Kara AliDepartment of Infectious Diseases and Clinical Microbiology, Tekirdağ Namik Kemal University Medical Faculty, Tekirdağ, Türkiye.ORCID 0000-0003-2440-7529
Rahmet GünerDepartment of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye.ORCID 0000-0002-1029-1185
Tansu YamazhanDepartment of Infectious Diseases and Clinical Microbiology, Ege University Medical Faculty, İzmir, Türkiye.ORCID 0000-0001-5950-0702
Sukran KoseDepartment of Infectious Diseases, Tepecik Training and Research Hospital, İzmir, Türkiye.ORCID 0000-0002-4228-1213
Nurettin ErbenDepartment of Infectious Diseases and Clinical Microbiology, Eskişehir Osman Gazi University, Eskişehir, Türkiye.ORCID 0000-0003-0373-0132
Nevin InceDepartment of Infectious Diseases and Clinical Microbiology, Düzce University Medical Faculty, Düzce, Türkiye.ORCID 0000-0002-0129-4536
İftihar KöksalDepartment of Infectious Diseases and Clinical Microbiology, Karadeniz Teknik University Medical Faculty, Trabzon, Türkiye.ORCID 0000-0003-4892-8935
Figen Sarıgül YıldırımDepartment of Infectious Diseases, Antalya Training and Research Hospital, Antalya, Türkiye.ORCID 0000-0001-8646-2203
Gulsen YorukDepartment of Infectious Diseases, İstanbul Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-0357-5884
Suheyla KomurDepartment of Infectious Diseases and Clinical Microbiology, Çukurova University Medical Faculty, Adana, Türkiye.ORCID 0000-0003-2414-559X
Tayibe BalDepartment of Infectious Diseases and Clinical Microbiology, Mustafa Kemal University Medical Faculty, Hatay, Türkiye.ORCID 0000-0002-5315-122X
Sibel KayaDepartment of Infectious Diseases and Clinical Microbiology, İstanbul University-Cerrahpaşa Cerrahpaşa Medical Faculty, İstanbul, Türkiye.ORCID 0000-0003-4932-3188
Şaban EsenDepartment of Infectious Diseases and Clinical Microbiology, Samsun 19 Mayıs University Medical Faculty, Samsun, Türkiye.ORCID 0000-0002-7947-4692
Özgür GünalDepartment of Infectious Diseases and Clinical Microbiology, Samsun Training and Research Hospital, Samsun, Türkiye.ORCID 0000-0002-7744-4123
Ilknur Esen YıldızDepartment of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Medical Faculty, Rize, Türkiye.ORCID 0000-0003-2987-0483
Dilara InanDepartment of Infectious Diseases and Clinical Microbiology, Akdeniz University Medical Faculty, Antalya, Türkiye.ORCID 0000-0002-7551-6728
Şener BarutDepartment of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa University Medical Faculty, Tokat, Türkiye.ORCID 0000-0003-2047-8573
Mustafa NamıduruDepartment of Infectious Diseases and Clinical Microbiology, Gaziantep University Medical Faculty, Gaziantep, Türkiye.ORCID 0000-0001-9890-7142
Selma TosunDepartment of Infectious Diseases, Bozyaka Training and Research Hospital, İzmir, Türkiye.ORCID 0000-0001-9844-9399
Kamuran TürkerDepartment of Infectious Diseases, Bağcılar Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-5050-3832
Alper SenerDepartment of Infectious Diseases and Clinical Microbiology, Çanakkale 18 Mart University Medical Faculty, Çanakkale, Türkiye.ORCID 0000-0003-2774-8601
Kenan HızelDepartment of Infectious Diseases and Clinical Microbiology, Gazi University Medical Faculty, Ankara, Türkiye.ORCID 0000-0001-8644-139X
Nurcan BaykamDepartment of Infectious Diseases and Clinical Microbiology, Hitit University Medical Faculty, Çorum, Türkiye.ORCID 0000-0002-2398-8686
Fazilet DuyguDepartment of Infectious Diseases, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Türkiye.ORCID 0000-0002-0383-2887
Esragül AkıncıDepartment of Infectious Diseases, Ankara Numune Training and Research Hospital, Ankara, Türkiye.ORCID 0000-0003-3412-8929
Güray CanDepartment of Gastroenterology, Bolu İzzet Baysal University Medical Faculty, Bolu, Türkiye.ORCID 0000-0002-6054-9244
Ulku UserDepartment of Infectious Diseases, Antalya Training and Research Hospital, Antalya, Türkiye.ORCID 0000-0001-7966-3234
Hanefi Cem GülDepartment of Infectious Diseases, Gülhane Training and Research Hospital, Ankara, Türkiye.ORCID 0000-0001-7648-322X
Ayhan AkbulutDepartment of Infectious Diseases and Clinical Microbiology, Fırat University Medical Faculty, Elazığ, Türkiye.ORCID 0000-0003-2560-3265
Güven ÇelebiDepartment of Infectious Diseases and Clinical Microbiology, Bülent Ecevit University Medical Faculty, Zonguldak, Türkiye.ORCID 0000-0003-4035-6864
Mahmut SünnetçioğluDepartment of Infectious Diseases and Clinical Microbiology, Yüzüncü Yıl University Medical Faculty, Van, Türkiye.ORCID 0000-0003-1930-6651
Oğuz KarabayDepartment of Infectious Diseases and Clinical Microbiology, Sakarya University Medical Faculty, Hatay, Türkiye.ORCID 0000-0003-1514-1685
Hayat Kumbasar KaraosmanoğluDepartment of Infectious Diseases, Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-7716-3006
Fatma SırmatelDepartment of Infectious Diseases and Clinical Microbiology, Bolu İzzet Baysal University Medical Faculty, Bolu, Türkiye.ORCID 0000-0003-0442-5981
Fehmi TabakDepartment of Infectious Diseases and Clinical Microbiology, İstanbul University-Cerrahpaşa Cerrahpaşa Medical Faculty, İstanbul, Türkiye.ORCID 0000-0001-8632-2825
Hep-C Turkey Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: Chronic hepatitis C virus (HCV) infection constitutes a substantial healthcare concern in Türkiye. The clinical application of direct-acting antiviral medications (DAAs) has transformed its management. The goal is to assess the efficacy and safety of DAAs in the real-world setting in Turkish patients with chronic HCV. Materials and Methods: Thirty-seven centers from Türkiye recorded 1807 patients to the database. Patients aged >18 years were enrolled to the study. Their demographics, clinical information, DAAs used, efficacy, and safety information were evaluated. Efficacy and safety results were reported for patients with 12-week post-treatment (SVR12) data. Results: Among the patients, 919 (50.9%) were female with a mean of age 56 ± 15 years (range:18-97 years) and 238 (13%) were cirrhotic. Liver biopsy was performed in 296 patients. Mean histologic activity index score was 7.68 and fibrosis score was 2.58. Baseline mean viral load was 4.11×106 copies/mL. Patients received the following treatments: Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir (PrOD):706, Ledipasvir+Sofosbuvir:490, Sofosbuvir+Ribavirin:176, PrOD+Ribavirin:175, Ledipasvir+Sofosbuvir+Ribavirin:156, PrO+Ribavirin:32, and PrO:10. Response at the end of treatment was 99.2% (1454/1465) and SVR12 was 97.8% (1289/1318). The DAAs were generally well tolerated. Ten and 13 patients discontinued therapy because of drug-related and unrelated adverse side effects, respectively. Conclusion: This real-world study demonstrated that DAA treatment for HCV is both safe and highly effective. In two-thirds of the patients, the hepatic inflammation is moderate to severe, and fibrosis is moderate to advanced in half of them. Patients' characteristics suggest that HCV infection is often not diagnosed or treated until patients present with moderate-to-severe stage, indicating that diagnostic and therapeutic approaches should be used more effectively.

Indexed as

Antiviralchronic hepatitis Cdrug safetytreatment effectiveness

Identifiers

PMID42041139
PMCPMC13247864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.